Ovarian cryopreservation by vitrification is a highly useful method for preserving female fertility during radiotherapy and chemotherapy. However, cryoinjury, osmotic stress during vitrification, and ischemia/reperfusion during transplantation lead to loss of ovarian follicles. Ovarian follicle loss may be partially reduced by several methods; however, studies regarding the mechanism of ovarian follicle loss have only investigated cell apoptosis, which consists of type I programmed cell death. Autophagy is type II programmed cell death, and cell homeostasis is maintained by autophagy during conditions of stress. The role of autophagy during cryopreservation by vitrification has rarely been reported. The potential role of autophagy during ovarian cryopreservation by vitrification is reviewed in this article.
INTRODUCTION
Cryopreservation of ovarian tissue by vitrification to preserve fertility for patients with cancer has been investigated for decades. To date, the birth of more than 60 babies from the transplantation of cryopreserved ovarian tissue has demonstrated the clinical success of this method [1] , and two of these babies were born from vitrified ovarian tissues/follicles. Following recovery from cancer, patients with ovarian transplantation exhibit a complete return of hormonal function and fertility to baseline [2] . Thus, ovarian tissue cryopreservation by vitrification is considered the most significant method for preserving female fertility, especially for young women undergoing chemotherapy. Ovarian damages are often acquired during the process of chemotherapy; specifically the number of reserved primordial follicles is reduced, which further triggers premature ovarian failure [3, 4] . Thus, ovarian vitrification and the transplantation of vitrified/warmed ovaries has emerged as an effective method of preserving ovarian function. However, there are numerous problems with the vitrification process, including follicle loss triggered by cryoinjury, osmotic stress during vitrification, and ischemia/ reperfusion during transplantation. Specifically, ischemia/ reperfusion causes the death of most primordial follicles [5] [6] [7] . However, the mechanism of primordial follicle loss in vitrified ovaries and transplanted ovaries remains completely unknown. Most studies have suggested that the death and loss of ovarian follicles during ovarian vitrification and ovarian grafts is primarily caused by apoptosis. Thus, antiapoptotic agents are used to preserve the survival of ovarian follicles [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] ; however, the death of ovarian follicles is only partially decreased with limited follicle survival following antiapoptotic agent administration.
Previous studies have suggested that oocyte death-mediated primordial follicle atresia and granulosa cell death-mediated primary, secondary, tertiary, and mature follicle atresia involve an apoptotic-dependent pathway [20] [21] [22] [23] [24] [25] [26] . Therefore, the mechanism of ovarian follicle loss during ovarian vitrification and transplantation has been considered apoptosis. It remains unknown whether another important pathway is involved in ovarian follicle loss.
Autophagy is an intracellular bulk degradation system in which a portion of the cytoplasm is enveloped in doublemembrane-bound structures referred to as autophagosomes, which undergo maturation and fusion with lysosomes for degradation [27, 28] .
At a baseline level, autophagy promotes cellular survival; when activated under stress conditions, such as nutrient deprivation [29] , hypoxia [30] , and ischemia/reperfusion [31] , autophagy may lead to cell death. Therefore, autophagy is often dubbed a ''double-edged sword'' because it is a necessary process for many cells, but its amplification may lead to cell death [32] .
Autophagy consists of type II programmed cell death, and its roles in primordial follicle atresia and granulosa cell apoptosis have been demonstrated [33] [34] [35] [36] [37] . Nevertheless, whether autophagy is involved in follicle death during ovarian vitrification and transplantation remains uncertain. Thus, the potential roles of autophagy in ovarian vitrification and transplantation are summarized in this article.
WHETHER FOLLICLE DEATH OCCURS DURING OVARIAN VITRIFICATION
Conclusions from previous studies that have demonstrated apoptosis is triggered by cryoinjury from liquid nitrogen during the vitrification process remain controversial. Most articles have suggested that apoptosis is initiated during ovarian vitrification; however, the apoptotic rate may be decreased during ovarian vitrification by the administration of several antiapoptotic reagents [11, 12, [14] [15] [16] 38] , and apoptosis may be decreased by use of the optimal protocol [39] [40] [41] [42] [43] [44] . In contrast, other studies have suggested that there is no apoptosis in ovarian vitrification [45, 46] , which is attributed to the application of the optimal protocol. However, it remains unknown whether follicle death is initiated by an apoptosisindependent pathway.
Two views exist regarding ovarian vitrification: on one hand, apoptosis is triggered in ovarian follicles during vitrification, but on the other hand, apoptosis is not triggered in ovarian follicles during vitrification with the optimal protocol. Thus, three questions arise: if the death of ovarian follicles is initiated by cryoinjury, which pathway comprises the trigger for ovarian follicle death; is there another cell death pathway in addition to the apoptotic pathway that may be initiated by cryoinjury; and if ovarian follicle death is not initiated by cryoinjury, which pathway is initiated to adapt to the stress of cryoinjury?
APOPTOSIS IS NOT SOLELY RESPONSIBLE FOR FOLLI-CLE LOSSES FROM OVARIAN GRAFTS
Previous studies have suggested that 60%-95% of follicular reserve is depleted during autografting, which induces the loss of virtually the entire population of growing follicles [5, [47] [48] [49] . Ovarian follicle losses occur during the early period of ovarian transplantation, which is caused by tissue ischemia and reperfusion injury [50, 51] . The effects of hypoxia following transplantation decrease the reproductive viability of ovarian transplants [52, 53] . Therefore, angiogenesis, which is composed of formation of new blood vessels, is important for the survival of ovarian transplants and restoration of ovarian function [52] . The damage of transplanted vitrified/ warmed ovaries is reduced by simvastatin [17] , which decreases apoptosis and stimulates angiogenesis and endothelial cell migration in ovarian grafts through sphingosine-1-phosphate (S1P) [13] . Erythropoietin increases angiogenesis in ovarian grafts [54] . Isoform 165 of vascular endothelial growth factor [55] decreases apoptosis, and oxidative stress is inhibited by N-acetylcysteine [18] . Reductions of follicle loss and increasing angiogenesis are 2 core objectives during ovarian transplantation, and 3 issues must be resolved, as follows. First, previous studies have suggested that follicle loss is triggered by apoptosis; however, it remains unknown whether other cellular death pathways are also initiated in ovarian grafts. Second, the potential mechanism of angiogenesis during ovarian transplantation must be investigated. Third, primordial follicle intense activation is another pathway for follicle reserve depletion; thus, whether this pathway is initiated during ovarian transplantation, as well as the mechanism of primordial follicle intense activation, must be investigated.
IMPORTANCE OF AUTOPHAGY IN OVARIAN FOLLICLE ATRESIA AND DEPLETION OF FOLLICLE RESERVE
Autophagy is an evolutionarily conserved mechanism, and it is indispensable for mammalian reproduction [56, 57] , from gametogenesis to parturition [57] , including embryogenesis [58] , fertilization [59] , spermatogenesis [60] , and development of human placenta [61] .
Previous studies have suggested that autophagy is involved in oocyte death-mediated primordial follicle atresia but not apoptosis [33] . Moreover, autophagy-mediated granulosa cell apoptosis is involved in primary, secondary, tertiary, and mature follicle atresia [34, 35] . Thus, the importance of autophagy in primordial follicle atresia is supported by several studies. Primordial follicle atresia is not a result of apoptotic pathways [36, 37] ; it is attributed to an autophagy-dependent pathway [33] . Recent studies have suggested that apoptotic and autophagic proteins coexist in fetal oocytes [62] . Furthermore, germline cell death may be apoptotic or nonapoptotic, depending on the stimulus or stage of development [63] . These findings have emphasized the function of autophagy in primordial follicle atresia. Autophagic cell death has not been investigated in ovarian vitrification or ovarian grafts.
Another important role of autophagy in follicle reserve has been suggested by several studies in which autophagy is involved in the formation of the primordial follicle pool. Germ cell loss in perinatal mice is caused by the knockout of the autophagic genes Beclin 1 (Becn1) andautophagy-related gene 7 (Atg7); there is a 56% germ cell reduction in Becn1 þ/À mice, and no germ cells are detected in Atg7 À/À mice [64] . Germ cellspecific Atg7 knockout results in primary ovarian insufficiency in female mice, with germ cell over-loss during the neonatal transition period [65] . In addition, premature ovarian failure is consistently triggered by primordial follicle depletion through knockout of the autophagic activation gene phosphatase and tensin homolog deleted on chromosome 10 (PTEN) through negative regulation of PI3K [66] , which is a molecule upstream of mTOR. The autophagic activator rapamycin is an inhibitor of mTOR [67] . Inhibition of mTOR pathway activation increases the follicle reserve [68] . Thus, baseline level autophagy is indispensable for maintenance of the primordial follicle pool, and follicle death is triggered by excess activation of autophagy, whereas depletion of the primordial follicle pool is triggered by inhibition of autophagy.
IMPORTANCE OF AUTOPHAGY IN OVARIAN VITRIFI-CATION AND TRANSPLANTATION
Autophagy plays a role in ovarian follicle atresia and follicle reserve depletion. Our limited knowledge indicates that autophagy is involved in ovarian vitrification by triggering follicle atresia if ovarian follicle loss occurs in this process or if homeostasis is maintained under the optimal vitrification protocol during cryoinjury. Autophagy is triggered for cell survival in vitrified/warmed mouse oocytes; however, autophagy is activated not only in the cooling process but also in the warming stages [69] . Furthermore, Gallardo Bolaños et al. [70] suggest that autophagy is activated for pro-survival in the cryopreservation of stallion spermatozoa; however, apoptosis plays a major role in sperm death during storage.
Follicle losses are triggered by ischemia/reperfusion injury [50, 51] and hypoxia injury [51, 52] in ovarian grafts. These findings support the idea that autophagy is involved in the YANG ET AL.
follicle loss of ovarian grafts during ischemia/reperfusion injury and that hypoxia injury triggers follicle atresia or depletion of the primordial follicle pool. Indeed, autophagy mediates follicle atresia [33] [34] [35] [36] [37] and depletion of the primordial follicle pool [66, 68] . Furthermore, the importance of autophagy has been investigated during ischemia/reperfusion injury by several studies regarding liver transplantation [71] [72] [73] and renal transplantation [74] [75] [76] . In addition, a recent novel insight suggests that follicle activation and ''burn-out'' contribute to post-transplantation follicle loss in ovarian tissue grafts [53, 77] . This phenomenon may be attributable to the vitrification protocol, in which the protocol for vitrification after Amorim et al. [78] has a positive impact on the quiescent state of primordial follicles following xenografting and does not activate the resting follicle reserve [78] . It has consistently been hypothesized that massive activation of primordial follicles is a consequence of the ischemic stress to which the ovarian graft was subjected prior to tissue revascularization [14, 79] .
Second, revascularization and vascular remolding of the graft may be the most vital factor for success because it establishes the survival rate of the follicle pool within the graft [2] . The significance of autophagy for vascularization has been demonstrated in recent studies [80, 81] . Microvascular damage is associated with HIF-1-related autophagy [82] . Inhibition of autophagy may significantly enhance the antiangiogenic activity of the T7 peptide in endothelial cells [83] , and macroautophagy (autophagy) is an important factor that affects the function of the vascular endothelial cells that must be tightly regulated in these cells [84] . Therefore, autophagy plays an important role in vascularization [85] .
Hypoxia is another damage factor for ovarian follicles in ovarian grafts. Hypoxia inducible factor 1 (HIF1) is closely related to ovarian angiogenesis, especially regarding formation of corpus luteum and increased expression of VEGF [86] [87] [88] [89] ; however, hypoxia represents a disadvantage for ovarian grafts. Previous studies have demonstrated that a 6-h fetal ovary culture without hypoxia prior to transplantation improves graft viability and increases the proportion of primordial and preantral follicles [90] . Moreover, hypoxic preconditioning in vitro was not beneficial to grafts and worsened their viability [91] . However, ischemic preconditioning of the ovary improves graft quality [92, 93] . Autophagy is regulated at the molecular level in different hypoxic environments [94] . It is closely related to the apoptosis caused by hypoxia. Autophagy blocks induction of apoptosis and inhibits activation of apoptosis-associated caspase, which may reduce cellular injury. Autophagy or autophagy-relevant proteins may facilitate the induction of apoptosis, which may aggravate cell damage in hypoxic conditions [95] . Moreover, hypoxia induces autophagy in human vascular endothelial cells in an HIF1-dependent manner [82] .
Ovarian stromal cell fibrosis is another characteristic of ovarian grafts [53, 78] , and autophagy has been associated with fibrosis in studies of hepatic fibrosis [96, 97] , airway epithelial fibrosis [98] , pulmonary fibrosis [99] , and myocardial fibrosis [100] [101] [102] . However, whether autophagy accelerates or ameliorates fibrosis is dependent on the stimulus, and the role of autophagy in ovarian fibrosis is not known and remains to be elucidated.
ANTIAPOPTOSIS IS NOT THE ONLY MECHANISM OF INTERVENTION
Although ovarian follicle loss during ovarian vitrification and transplantation may be decreased by several interventional methods, the primary approach assumes that the mechanism of ovarian follicle loss is apoptosis. Ovarian loss has been partially decreased by antiapoptotic molecules, such as melatonin [8] [9] [10] , S1P [11] [12] [13] , Kit ligand [14] , catalase [15] , necrostatin [16] , simvastatin [17] , N-acetylcysteine [18] , and antifreeze protein [19] . Moreover, several studies have suggested that autophagy is regulated by melatonin [103, 104] and S1P [105] [106] [107] [108] . S1P-induced autophagy protects cells from death with apoptotic features during nutrient starvation [109] , and S1P induces autophagy toward cell survival [110] . These findings further demonstrate that autophagy is activated during ovarian vitrification and transplantation. However, whether apoptosis and autophagy crosstalk with each other remains unknown. Autophagy is an upstream regulator of apoptosis; it blocks the induction of apoptosis and inhibits the activation of apoptosis-associated caspase, which may reduce injury to cells. Autophagy or autophagy-relevant proteins may facilitate the induction of apoptosis, which may aggravate cell damage. In contrast, activation of the apoptosis-related protein caspase may also degrade autophagy-related proteins, such as Atg3, Atg4, and Beclin1, which inhibits autophagy [95] . These findings suggest that apoptosis is not the only pathway and that autophagy is involved in ovarian vitrification and transplantation.
CONCLUSIONS
Despite the partial decrease in ovarian follicle loss caused by several methods and the birth of 2 babies from vitrified ovaries, the mechanisms of ovarian follicle loss during ovarian vitrification and transplantation have not been fully elucidated. A comprehensive understanding of the mechanism of ovarian follicle loss would provide novel insights into the preservation of follicle survival during ovarian vitrification and transplantation and significantly increase the fertility rate for female cancer patients. The importance of autophagy during ovarian vitrification and transplantation was reviewed, as follows: first, autophagy is involved in the follicle atresia induced by cryoinjury during ovarian vitrification; second, autophagy maintains ovarian homeostasis and pro-survival for ovarian follicles during cryoinjury stress if there is no cell death attributable to the use of the optimal protocol; third, autophagy is involved in follicle loss through follicle atresia, and follicle reserve depletion is induced by ischemia/ reperfusion injury and hypoxic injury; and fourth, angiogenesis in ovarian grafts is regulated by autophagy. These findings regarding the importance of autophagy in ovarian vitrification and transplantation provide new insights for future studies that will focus on three points. The function of autophagy during cryoinjury in the process of ovarian vitrification, including the maintenance of ovarian homeostasis or involvement follicle atresia. The role of autophagy during ischemia/reperfusion injury and hypoxic injury in the process of transplantation, including the initiation of follicle atresia or follicle reserve depletion. The functions of autophagy in the angiogenesis to ovarian grafts.
